what is ss 31 peptide SS-31 is a novel mitochondria-targeted tetrapeptide - SS-31peptidesupplement a small peptide that accumulates in mitochondria and scavenges reactive oxygen species Unraveling the Science Behind SS-31 Peptide: A Mitochondria-Targeting Therapeutic

SS-31peptidedosage per day The quest for enhanced cellular health and the mitigation of age-related decline has led to significant interest in a novel compound known as SS-31 peptide. This mitochondria-targeting antioxidant has emerged as a promising therapeutic agent, demonstrating a remarkable ability to impact fundamental cellular processes. Understanding what is SS-31 peptide delves into its unique structure, mechanism of action, and the expanding range of its potential applications.

At its core, SS-31 peptide is a small peptide, specifically a tiny four amino acid peptide with the chemical designation D-Arg-dimethyl-Tyr-Lys-Phe-NH2. It is also recognized by several other names, including Elamipretide, Bendavia, and MTP-131. This water-soluble mitochondria-targeting peptide possesses a distinct characteristic: it selectively accumulates within mitochondria, particularly concentrating at the inner mitochondrial membrane. This targeted localization is crucial to its therapeutic efficacy.

The primary mechanism by which SS-31 peptide operates is by interacting with cardiolipin, a key phospholipid found predominantly in the inner mitochondrial membrane. This interaction is not merely passive; the mitochondria-targeted peptide SS-31 binds lipid bilayers and modulates surface electrostatics, playing a vital role in stabilizing mitochondrial structure and function.SS-31, or elamipretide, is a synthetic peptide that targets mitochondria. It binds to cardiolipin in the inner membrane, helping stabilize energy output and ... By targeting mitochondria, SS-31 effectively addresses mitochondrial dysfunction, a common hallmark of aging and various disease states.

One of the most significant contributions of SS-31 peptide is its role in restoring redox homeostasis. Mitochondria are central to cellular energy production through oxidative phosphorylation, but this process also generates reactive oxygen species (ROS), which can cause oxidative damage. SS-31 is a mitochondria-targeted antioxidant peptide that can effectively scavenge mitochondrial ROS, thereby reducing oxidative stress. This antioxidant capability is instrumental in protecting cells from damage and supporting their optimal function. Research has shown that SS-31 can decrease mitochondrial reactive oxygen species production, leading to improved cellular resilience.

The implications of SS-31 peptide's ability to enhance mitochondrial function are far-reaching. Clinical studies and preclinical research suggest its potential as a treatment for multiple aging-related changes, including those affecting cognition and overall physiology. By improving mitochondrial quality and energy production, SS-31 can lead to enhanced cellular energetics and repair作者：H Zhao·2017·被引用次数：79—SS-31 is a novel mitochondrion-targeted antioxidant, which accumulates in the inner mitochondrial membrane, where the electron transport chain .... This is particularly relevant in conditions where mitochondrial dysfunction contributes to pathology作者：MD Campbell·2019·被引用次数：138—Treatment withSS-31restores redox homeostasis, improves mitochondrial quality, and increases exercise tolerance without an increase in mitochondrial content.. For instance, studies have indicated that SS-31 targets NOS2 to enhance osteogenic differentiation in aged bone marrow mesenchymal stem cells, suggesting a role in bone health. Furthermore, SS-31 peptide has demonstrated beneficial effects on cardiac function and has been explored for its neuroprotective qualities by reversing mitochondrial dysfunction.Targeting Mitochondria by SS-31 Ameliorates the Whole Body ... - NIH

The therapeutic potential extends to specific medical conditions. SS-31 is a medication used for the treatment of Barth syndrome, a rare genetic disorder characterized by mitochondrial dysfunctionSS-31 (also known as Bendavia, Elamipretide, and MTP-131) isa small peptide that accumulates in mitochondria and scavenges reactive oxygen species.. Its ability to improve mitochondrial energy production and reduce oxidative stress makes it a valuable therapeutic agent in this context.SS-31 (also known as Elamipretide®, Bendavia®, and ... Beyond specific diseases, the broad impact on mitochondrial health positions SS-31 peptide as a potential intervention for age-related decline. Studies have shown that treatment with SS-31 can improve skeletal muscle energetics and exercise tolerance without increasing mitochondrial content, and it has been observed to rapidly rejuvenate oxidative phosphorylation in aged skeletal muscle.

In summary, SS-31 peptide represents a significant advancement in therapeutic development. As SS-31, or elamipretide, it is a breakthrough peptide designed to restore and protect mitochondrial function. Its targeted action within mitochondria, its potent antioxidant capabilities, and its role in enhancing cellular energy production underscore its potential to address a wide spectrum of health challenges, from age-related diseases to specific genetic disorders. The ongoing research into SS-31 peptide continues to reveal its multifaceted benefits, solidifying its position as a critical player in the future of mitochondrial medicine.